181 related articles for article (PubMed ID: 28827789)
1. Positional cloning of quantitative trait nucleotides for blood pressure and cardiac QT-interval by targeted CRISPR/Cas9 editing of a novel long non-coding RNA.
Cheng X; Waghulde H; Mell B; Morgan EE; Pruett-Miller SM; Joe B
PLoS Genet; 2017 Aug; 13(8):e1006961. PubMed ID: 28827789
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic Effect of a High Resolution Mapped Blood Pressure QTL on Tumorigenesis.
Cheng X; Waghulde H; Mell B; Smedlund K; Vazquez G; Joe B
PLoS One; 2016; 11(4):e0153519. PubMed ID: 27073989
[TBL] [Abstract][Full Text] [Related]
3. In Vivo CRISPR/Cas9-Based Targeted Disruption and Knockin of a Long Noncoding RNA.
Cheng X; Peters ST; Pruett-Miller SM; Saunders TL; Joe B
Methods Mol Biol; 2021; 2254():305-321. PubMed ID: 33326084
[TBL] [Abstract][Full Text] [Related]
4. Augmented rififylin is a risk factor linked to aberrant cardiomyocyte function, short-QT interval and hypertension.
Gopalakrishnan K; Morgan EE; Yerga-Woolwine S; Farms P; Kumarasamy S; Kalinoski A; Liu X; Wu J; Liu L; Joe B
Hypertension; 2011 Apr; 57(4):764-71. PubMed ID: 21357277
[TBL] [Abstract][Full Text] [Related]
5. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research.
Zhen S; Li X
Hum Gene Ther; 2019 Jan; 30(1):3-9. PubMed ID: 30045635
[TBL] [Abstract][Full Text] [Related]
6. Submegabase resolution of epistatically interacting quantitative trait loci for blood pressure applicable for essential hypertension.
Chauvet C; Charron S; Ménard A; Xiao C; Roy J; Deng AY
J Hypertens; 2008 May; 26(5):893-901. PubMed ID: 18398331
[TBL] [Abstract][Full Text] [Related]
7. Live cell imaging and proteomic profiling of endogenous NEAT1 lncRNA by CRISPR/Cas9-mediated knock-in.
Chen B; Deng S; Ge T; Ye M; Yu J; Lin S; Ma W; Songyang Z
Protein Cell; 2020 Sep; 11(9):641-660. PubMed ID: 32458346
[TBL] [Abstract][Full Text] [Related]
8. Locating a blood pressure quantitative trait locus within 117 kb on the rat genome: substitution mapping and renal expression analysis.
Garrett MR; Meng H; Rapp JP; Joe B
Hypertension; 2005 Mar; 45(3):451-9. PubMed ID: 15655120
[TBL] [Abstract][Full Text] [Related]
9. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
10. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does.
Petrezselyova S; Kinsky S; Truban D; Sedlacek R; Burtscher I; Lickert H
Cell Mol Biol Lett; 2015 Dec; 20(5):773-87. PubMed ID: 26540224
[TBL] [Abstract][Full Text] [Related]
11. QTL mapping of rat blood pressure loci on RNO1 within a homologous region linked to human hypertension on HSA15.
Mell B; Cheng X; Joe B
PLoS One; 2019; 14(8):e0221658. PubMed ID: 31442284
[TBL] [Abstract][Full Text] [Related]
12. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region.
Szafranski P; Karolak JA; Lanza D; Gajęcka M; Heaney J; Stankiewicz P
Mamm Genome; 2017 Aug; 28(7-8):275-282. PubMed ID: 28405742
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish.
Auer TO; Del Bene F
Methods; 2014 Sep; 69(2):142-50. PubMed ID: 24704174
[TBL] [Abstract][Full Text] [Related]
15. High-efficiency non-mosaic CRISPR-mediated knock-in and indel mutation in F0
Aslan Y; Tadjuidje E; Zorn AM; Cha SW
Development; 2017 Aug; 144(15):2852-2858. PubMed ID: 28694259
[TBL] [Abstract][Full Text] [Related]
16. Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.
Wang X; Liu J; Niu Y; Li Y; Zhou S; Li C; Ma B; Kou Q; Petersen B; Sonstegard T; Huang X; Jiang Y; Chen Y
BMC Genomics; 2018 May; 19(1):397. PubMed ID: 29801435
[TBL] [Abstract][Full Text] [Related]
17. Challenges of CRISPR/Cas9 applications for long non-coding RNA genes.
Goyal A; Myacheva K; Groß M; Klingenberg M; Duran Arqué B; Diederichs S
Nucleic Acids Res; 2017 Feb; 45(3):e12. PubMed ID: 28180319
[TBL] [Abstract][Full Text] [Related]
18. Multiple genome modifications by the CRISPR/Cas9 system in zebrafish.
Ota S; Hisano Y; Ikawa Y; Kawahara A
Genes Cells; 2014 Jul; 19(7):555-64. PubMed ID: 24848337
[TBL] [Abstract][Full Text] [Related]
19. Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
Chu VT; Weber T; Graf R; Sommermann T; Petsch K; Sack U; Volchkov P; Rajewsky K; Kühn R
BMC Biotechnol; 2016 Jan; 16():4. PubMed ID: 26772810
[TBL] [Abstract][Full Text] [Related]
20. Heritable CRISPR/Cas9-mediated genome editing in the yellow fever mosquito, Aedes aegypti.
Dong S; Lin J; Held NL; Clem RJ; Passarelli AL; Franz AW
PLoS One; 2015; 10(3):e0122353. PubMed ID: 25815482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
